Paraneoplastic granulocytosis in metastatic melanoma

Melanoma Research

Volumn 20, Issue 4, 2010, Pages 326-329

  Davis, Jeremy L ^a   Ripley, R Taylor ^a   Frankel, Timothy L ^a   Maric, Irina ^b   Lozier, Jay N ^b   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

granulocyte colony stimulating factor; melanoma; paraneoplastic syndromes

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEMOZOLOMIDE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CELL TRANSFER; CLINICAL ARTICLE; FEMALE; GRANULOCYTOSIS; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MELANOMA; METASTASIS; NEUTROPHIL COUNT; PARANEOPLASTIC GRANULOCYTOSIS; PRIORITY JOURNAL; URINARY TRACT INFECTION; BLOOD; COMPLICATION; GRANULOCYTE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PATHOLOGY; YOUNG ADULT;

ADULT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; MALE; MELANOMA; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; YOUNG ADULT;

EID: 77955708161     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328339da1e     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
2. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100:1672-1694.
3. American Cancer Society. Cancer facts and figures 2008. Atlanta, GA: American Cancer Society; 2008.
4. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-3634.
5. Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000; 18:3782-3793.
6. Rosenberg SA, Yang JC, White DE, Steinberg SM. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg 1998; 228:307-319.
7. Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999; 17:2745-2751.
8. Ahmann DL, Creagan ET, Hahn RG, Edmonson JH, Bisel HF, Schaid DJ. Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer 1989; 63:224-227.
9. Li Y, McClay EF. Systemic chemotherapy for the treatment of metastatic melanoma. Semin Oncol 2002; 29:413-426.
10. Boyiadzis M, Lieberman FS, Geskin LJ, Foon KA. Paraneoplastic syndromes. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 8th ed. New York: Lippincott, Williams & Wilkins; 2008. pp. 2343-2362.
11. Brown WH. A case of pluriglandular syndrome: diabetes of bearded women. Lancet 1928; 2:1022-1023.
12. Kurkjian CD, Ozer H. Leukopenia anemia and thrombocytopenia. In: DeVita VTLT, Rosenberg SA, editors. Cancer: principles and practice of oncology. 8th ed. New York: Lippincott, Williams & Wilkins; 2008. pp. 2617-2633.
13. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001; 92:2399-2405.
14. Furihata M, Sonobe H, Iwata J, Ido E, Ohtsuki Y, Asahi Y, et al. Lung squamous cell carcinoma producing both parathyroid hormone-related peptide and granulocyte colony stimulating factor. Pathol Int 1996; 46:376-379.
15. Araki K, Kishihara F, Takahashi K, Matsumata T, Shimura T, Suehiro T, et al. Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 2007; 27:716-721.
16. Qureshi KM, Raman AK, Tan D, Fakih MG. Leukemoid reaction in pancreatic cancer: a case report and review of the literature. Jop 2006; 7:631-634.
17. Jardin F, Vasse M, Debled M, Dominique S, Courville P, Callonnec F, et al. Intense paraneoplastic neutrophilic leukemoid reaction related to a G-CSFsecreting lung sarcoma. Am J Hematol 2005; 80:243-245.
18. Turalic H, Deamant FD, Reese JH. Paraneoplastic production of granulocyte colony-stimulating factor in a bladder carcinoma. Scand J Urol Nephrol 2006; 40:429-432.
19. Hirasawa K, Kitamura T, Oka T, Matsushita H. Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein. J Urol 2002; 167:2130.
20. Melhem MF, Meisler AI, Saito R, Finley GG, Hockman HR, Koski RA. Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction. Blood 1993; 82:2038-2044.
21. Hintzen RQ, Voormolen J, Sonneveld P, van Duinen SG. Glioblastoma causing granulocytosis by secretion of granulocyte-colony-stimulating factor. Neurology 2000; 54:259-261.
22. Wagner RF Jr, Nathanson L. Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma. J Am Acad Dermatol 1986; 14 (2 Pt 1):249-256.
23. Lilly MB, Devlin PE, Devlin JJ, Rado TA. Production of granulocyte colonystimulating factor by a human melanoma cell line. Exp Hematol 1987; 15:966-971.
24. Schniewind B, Christgen M, Hauschild A, Kurdow R, Kalthoff H, Klomp HJ. Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line. Cancer Biol Ther 2005; 4:23-27.
25. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 2001; 61:4756-4760.
26. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005; 65:3044-3048.
27. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68:820-823.